Reportable condition changes: 1) added Bacillus cereus infections caused by strains that express anthrax toxin genes (pXO1 and/or pXO2 plasmids), including B. cereus biovar anthracis. This was added to the anthrax case definition by CSTE in 2017. These infections are rare, but will cause an anthrax-like illness, and should be treated like an anthrax infection; 2) added Candida auris or Candida haemulonii from any body site. These are emerging diseases causing concern for both multidrug resistance and healthcare transmission; 3) added Chagas disease. There is evidence that the vector for this disease may be present in Utah, which makes addition of this disease important as a potential emerging infection; 4) added Middle-East Respiratory Syndrome (MERS); 5) added a section mandating antimicrobial susceptibility testing when performed on 1 of 12 different organisms; 6) clarified that syphilitic stillbirths are reportable as syphilis cases; 7) clarified acute, chronic, and perinatal hepatitis C are all reportable; 8) specified encephalitis due to any organism (bacterial, fungal, parasitic, protozoan, and viral) is reportable; 9) removed aseptic meningitis; and 10) removed Staphyloccus aureus with vancomycin-intermediate resistance (VISA). Reportable through electronic laboratory reporting changes: 1) added positive influenza tests; 2) added Pseudomonas aeruginosa, resistant to a carbapenem, or with demonstrated carbapenemase production; and 3) added methicillin-susceptible Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA) from normally sterile sites. Mandatory submission of clinical material changes: 1) added Candida auris or Candida haemulonii from any body site; 2) added carbapenem resistant Acinetobacter species, Enterobacter species, Escherichia coli, Klebsiella species, and Pseudomonas aeruginosa; and 3) removed vancomycin intermediate Staphylococcus aureus. Additional changes are: 1) mandated electronic laboratory reporting from laboratories. Electronic Laboratory Reporting (ELR) is the electronic transmission of data from the laboratories to the public health of laboratory reports which identify reportable conditions; 2) incorporated by reference reporting specification documents; 3) authorized electronic case reporting as an acceptable reporting method; 4) updated the Special Measures for the Control of HIV/AIDS. Specifically, revised definitions and added a definition for re-engagement to care; 5) added language specifying that entities ordering a laboratory test for a reportable communicable disease must provide the performing laboratory with the patient?s address so that the laboratory can report to the appropriate jurisdiction; 6) corrected references throughout the rule; and 7) updated reference information in the "Official References" section.